Author: "Faye M. Johnson" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Faye M. Johnson"' showing total 500 results

Start Over Author "Faye M. Johnson"

500 results on '"Faye M. Johnson"'

201. Multiregion gene-expression profiling to reveal heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer

Author: Won-Chul Lee, Andrew Futreal, Weiyi Peng, Stephen G. Swisher, Cesar A. Moran, Jing Wang, Ignacio I. Wistuba, Carmen Behrens, Tina Cascone, Neda Kalhor, William N. William, Emily Roarty, Faye M. Johnson, Chi-Wan Chow, John V. Heymach, Jianjun Zhang, Jianhua Zhang, Junya Fujimoto, and Lixia Diao
Subjects: Cancer Research, business.industry, medicine.medical_treatment, Cancer, Immunotherapy, medicine.disease, Gene expression profiling, Oncology, Gene expression, Cancer research, medicine, business, Lung cancer, Exome
Abstract: e20077 Background: Intra-tumor heterogeneity (ITH) may be present in all molecular levels. Genomic ITH at the exome level has been reported in many cancer types, but comprehensive gene expression ITH has not been well studied. Methods: We collected 35 samples from 10 NSCLC patients (3 or 4 regions/tumor) including lung adenocarcinoma (n = 6), squamous cell carcinoma (n = 2), large cell carcinoma (n = 1) and pleomorphic carcinoma (n = 1). Using Affymetrix Gene 1.0 ST arrays, we generated the gene expression data for each sample. Diverse gene expression signatures associated with clinical outcomes were tested for ITH. Results: Inter-tumor heterogeneity was generally higher than intra-tumor heterogeneity, but some tumors showed a substantial level of ITH. The analysis of various clinically relevant gene expression signatures including molecular subtype, EMT and immunotherapy response signatures also revealed heterogeneity between different regions of the same tumor. The gene expression ITH we observed was associated with heterogeneous tumor microenvironments represented by stromal and immune cells infiltrated. Conclusions: Our data suggest that RNA-based prognostic or predictive molecular tests should be carefully conducted in consideration of the gene expression ITH.
Published: 2017

202. A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma

Author: Patrick Kwok Shing Ng, John V. Heymach, Lixia Diao, Jeffrey N. Myers, Bonnie S. Glisson, Gordon B. Mills, Faye M. Johnson, Shaohua Peng, Lauren Averett Byers, Katherine Stemke-Hale, Tuhina Mazumdar, and You Hong Fan
Subjects: MAPK/ERK pathway, Cancer Research, medicine.disease_cause, Bioinformatics, Receptor tyrosine kinase, Article, Cell Line, Tumor, medicine, Biomarkers, Tumor, Humans, Protein kinase B, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Phosphoinositide-3 Kinase Inhibitors, Mutation, biology, Squamous Cell Carcinoma of Head and Neck, MEK inhibitor, medicine.disease, Head and neck squamous-cell carcinoma, Oncology, Drug Resistance, Neoplasm, Head and Neck Neoplasms, Cancer research, biology.protein, Carcinoma, Squamous Cell, Signal transduction, Signal Transduction
Abstract: The PI3K/AKT/mTOR pathway is frequently activated in head and neck squamous cell carcinoma (HNSCC), but pathway inhibition has variable efficacy. Identification of predictive biomarkers and mechanisms of resistance would allow selection of patients most likely to respond and novel therapeutic combinations. The purpose of this study was to extend recent discoveries regarding the PI3K/AKT/mTOR pathway in HNSCC by more broadly examining potential biomarkers of response, by examining pathway inhibitors with a diverse range of targets, and by defining mechanisms of resistance and potential combination therapies. We used reverse-phase protein arrays (RPPA) to simultaneously evaluate expression of 195 proteins; SNP array to estimate gene copy number; and mass array to identify mutations. We examined altered signaling at baseline and after pathway inhibition. Likewise, we examined the activation of the PI3K/AKT/mTOR pathway in HNSCC tumors by RPPA. Cell lines with PIK3CA mutations were sensitive to pathway inhibitors, whereas amplification status did not predict sensitivity. While we identified a set of individual candidate biomarkers of response to pathway inhibitors, proteomic pathway scores did not correlate with amplification or mutation and did not predict response. Several receptor tyrosine kinases, including EGFR and ERK, were activated following PI3K inhibition in resistant cells; dual pathway inhibition of PI3K and EGFR or MEK demonstrated synergy. Combined MEK and PI3K inhibition was markedly synergistic in HRAS-mutant cell lines. Our findings indicate that clinical trials of single-agent PI3K/AKT/mTOR pathway inhibitors in selected populations and of PI3K/EGFR or PI3K/MEK inhibitor combinations are warranted; we plan to conduct such trials. Mol Cancer Ther; 13(11); 2738–50. ©2014 AACR.
Published: 2014

203. A high-throughput drug screen identifies new therapeutic vulnerabilities in non-small cell lung cancers (NSCLC) with overexpression of the EMT-associated receptor tyrosine kinase AXL

Author: John V. Heymach, J. Wang, H. Tran, R. Cardnell, Jayanthi Gudikote, Faye M. Johnson, P. Tong, Lauren Averett Byers, U. Banerjee, Uma Giri, Youhong Fan, Nene N. Kalu, and Monique B. Nilsson
Subjects: Drug, Cancer Research, Lung, biology, business.industry, media_common.quotation_subject, Pharmacology, Receptor tyrosine kinase, medicine.anatomical_structure, Oncology, biology.protein, Cancer research, medicine, Non small cell, business, Throughput (business), media_common
Published: 2016

204. Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway

Author: Faye M. Johnson, Sun Phil Choi, Jung Weon Lee, Scott M. Lippman, Bonnie S. Glisson, Kapil Mehta, Hyo Jong Lee, Ho-Young Lee, Mi Sook Lee, Hye-Young Min, and Dong Hoon Shin
Subjects: Cancer Research, Lung Neoplasms, Integrin, Blotting, Western, Fluorescent Antibody Technique, Mice, Nude, Antineoplastic Agents, Enzyme-Linked Immunosorbent Assay, Antibodies, Monoclonal, Humanized, Article, Receptor, IGF Type 1, CSK Tyrosine-Protein Kinase, chemistry.chemical_compound, Mice, Carcinoma, Non-Small-Cell Lung, medicine, Animals, Humans, Immunoprecipitation, Phosphorylation, Protein kinase B, Protein Kinase Inhibitors, Insulin-like growth factor 1 receptor, Analysis of Variance, biology, Squamous Cell Carcinoma of Head and Neck, Integrin beta3, Cixutumumab, Antibodies, Monoclonal, medicine.disease, Head and neck squamous-cell carcinoma, Xenograft Model Antitumor Assays, src-Family Kinases, Oncology, chemistry, Drug Resistance, Neoplasm, Head and Neck Neoplasms, Monoclonal, biology.protein, Cancer research, Carcinoma, Squamous Cell, Signal transduction, Proto-Oncogene Proteins c-akt, Proto-oncogene tyrosine-protein kinase Src, Signal Transduction
Abstract: Several phase II/III trials of anti-insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibodies (mAbs) have shown limited efficacy. The mechanisms of resistance to IGF-1R mAb-based therapies and clinically applicable strategies for overcoming drug resistance are still undefined.IGF-1R mAb cixutumumab efficacy, alone or in combination with Src inhibitors, was evaluated in 10 human head and neck squamous cell carcinoma (HNSCC) and six non-small cell lung cancer (NSCLC) cell lines in vitro in two- or three-dimensional culture systems and in vivo in cell line- or patient-derived xenograft tumors in athymic nude mice (n = 6-9 per group). Cixutumumab-induced changes in cell signaling and IGF-1 binding to integrin β3 were determined by Western or ligand blotting, immunoprecipitation, immunofluorescence, and cell adhesion analyses and enzyme-linked immunosorbent assay. Data were analyzed by the two-sided Student t test or one-way analysis of variance.Integrin β3-Src signaling cascade was activated by IGF-1 in HNSCC and NSCLC cells, when IGF-1 binding to IGF-1R was hampered by cixutumumab, resulting in Akt activation and cixutumumab resistance. Targeting integrin β3 or Src enhanced antitumor activity of cixutumumab in multiple cixutumumab-resistant cell lines and patient-derived tumors in vitro and in vivo. Mean tumor volume of mice cotreated with cixutumumab and integrin β3 siRNA was 133.7 mm(3) (95% confidence interval [CI] = 57.6 to 209.8 mm(3)) compared with those treated with cixutumumab (1472.5 mm(3); 95% CI = 1150.7 to 1794.3 mm(3); P.001) or integrin β3 siRNA (903.2 mm(3); 95% CI = 636.1 to 1170.3 mm(3); P.001) alone.Increased Src activation through integrin ανβ3 confers considerable resistance against anti-IGF-1R mAb-based therapies in HNSCC and NSCLC cells. Dual targeting of the IGF-1R pathway and collateral integrin β3-Src signaling module may override this resistance.
Published: 2013

205. Spindle epithelial tumor with thymus-like differentiation: A case report and comprehensive review of the literature and treatment options

Author: Gonzalo, Recondo, Naifa, Busaidy, Jeremy, Erasmus, Michelle D, Williams, and Faye M, Johnson
Subjects: Adult, Male, Biopsy, Needle, Carcinoma, Thymus Neoplasms, Combined Modality Therapy, Immunohistochemistry, Risk Assessment, Carcinoma, Papillary, Neoplasms, Multiple Primary, Rare Diseases, Treatment Outcome, Chemotherapy, Adjuvant, Thyroid Cancer, Papillary, Thyroidectomy, Humans, Neoplasms, Glandular and Epithelial, Thyroid Neoplasms
Abstract: Spindle epithelial tumor with thymus-like differentiation (SETTLE) is a rare cancer of thymic origin with little information available for treating clinicians.We performed a comprehensive literature search and updates were requested from all authors. We report one recent case.We present the most comprehensive review of the clinical literature for SETTLE. We identified 41 published cases. SETTLE usually presents as an asymptomatic neck mass. Most patients successfully underwent surgical resection of the primary tumor. The mean latency to develop metastasis was 10 years. SETTLE is uniformly responsive to radiotherapy and combination chemotherapy in the rare cases where response data are available.Although SETTLE is initially indolent, it has the capacity to metastasize late in its course. The malignant potential of this tumor might be underestimated because of the lack of long-term follow-up. In cases in which complete surgical resection is not possible, radiotherapy or combination chemotherapy is effective.
Published: 2013

206. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers

Author: Diana Bell, Shaohua Peng, Adrian Woolfson, Michelle D. Williams, Matthew V. Lorenzi, Yiqun Zhang, Chad J. Creighton, Jeffrey N. Myers, Stephen Y. Lai, Tuhina Mazumdar, Faye M. Johnson, and Banibrata Sen
Subjects: endocrine system, Pathology, medicine.medical_specialty, Stromal cell, Cellular differentiation, General Biochemistry, Genetics and Molecular Biology, Mice, 03 medical and health sciences, 0302 clinical medicine, Patient-derived xenograft, medicine, Carcinoma, Animals, Humans, Head and neck cancer, Protein Kinase Inhibitors, Cell Proliferation, Janus Kinases, 030304 developmental biology, Medicine(all), Regulation of gene expression, 0303 health sciences, Squamous Cell Carcinoma of Head and Neck, Biochemistry, Genetics and Molecular Biology(all), business.industry, Research, Cell Differentiation, General Medicine, medicine.disease, Xenograft Model Antitumor Assays, Head and neck squamous-cell carcinoma, 3. Good health, Squamous carcinoma, Gene Expression Regulation, Neoplastic, Disease Models, Animal, src-Family Kinases, Translational animal models, Head and Neck Neoplasms, Cell culture, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Immunohistochemistry, Gene expression, Stromal Cells, business
Abstract: Background The patient-derived xenograft (PDX) model is likely to reflect human tumor biology more accurately than cultured cell lines because human tumors are implanted directly into animals; maintained in an in vivo, three-dimensional environment; and never cultured on plastic. PDX models of head and neck squamous cell carcinoma (HNSCC) have been developed previously but were not well characterized at the molecular level. HNSCC is a deadly and disfiguring disease for which better systemic therapy is desperately needed. The development of new therapies and the understanding of HNSCC biology both depend upon clinically relevant animal models. We developed and characterized the patient-derived xenograft (PDX) model because it is likely to recapitulate human tumor biology. Methods We transplanted 30 primary tumors directly into mice. The histology and stromal components were analyzed by immunohistochemistry. Gene expression analysis was conducted on patient tumors and on PDXs and cell lines derived from one PDX and from independent, human tumors. Results Five of 30 (17%) transplanted tumors could be serially passaged. Engraftment was more frequent among HNSCC with poor differentiation and nodal disease. The tumors maintained the histologic characteristics of the parent tumor, although human stromal components were lost upon engraftment. The degree of difference in gene expression between the PDX and its parent tumor varied widely but was stable up to the tenth generation in one PDX. For genes whose expression differed between parent tumors and cell lines in culture, the PDX expression pattern was very similar to that of the parent tumor. There were also significant expression differences between the human tumors that subsequently grew in mice and those that did not, suggesting that this model enriches for cancers with distinct biological features. The PDX model was used successfully to test targeted drugs in vivo. Conclusion The PDX model for HNSCC is feasible, recapitulates the histology of the original tumor, and generates stable gene expression patterns. Gene expression patterns and histology suggested that the PDX more closely recapitulated the parental tumor than did cells in culture. Thus, the PDX is a robust model in which to evaluate tumor biology and novel therapeutics.
Published: 2013

207. Abstract 3793: Cell-based, high-throughput screen for small molecule inducers of cell death in HPV-associated head and neck cancers

Author: Pan Tong, Jing Wang, Lauren Averett Byers, Faye M. Johnson, Nene N. Kalu, Li Shen, and Tuhina Mazumdar
Subjects: Oncology, Cancer Research, medicine.medical_specialty, Programmed cell death, business.industry, Small molecule, Internal medicine, medicine, Inducer, Head and neck, business, Throughput (business), Cell based
Abstract: High-risk human papillomavirus (HPV) is an oncogenic virus associated with 90% of cervical cancers, over 60% of oropharyngeal carcinoma cases and over 90% of anogenital cancers. Although HPV-positive cancers are molecularly, clinically and epidemiologically distinct from HPV-negative cancers, there are no specific or targeted therapies for HPV-positive cancers. In order to identify small molecule inhibitors that target HPV-positive cancers, we performed a high throughput drug screen on 24 cervical cancer and head and neck squamous cell carcinoma (HNSCC) cell lines (12 HPV-positive and 12 HPV-negative) to determine if these cell lines display differential sensitivity based on HPV status. HPV-positive cell lines with doubling times of less than 72 hours were selected for the screen. Unsupervised clustering of HNSCC cell lines based on protein expression levels obtained from reverse phase protein array (RPPA) was used to select matched HPV-negative cell lines by Spearman's rank-order correlation. Cytotoxic chemotherapeutics and agents targeting a broad range of processes including cell cycle control and DNA damage response were obtained from commercial vendors and academic collaborators. Drug sensitivity was measured by using nuclear staining to monitor cell death and proliferation after 72h of treatment. The screen of 1062 unique compounds at 6 different concentrations (0-3μM) in 24 cell lines represents 25,448 cell line – drug interactions. To ensure the robustness and reproducibility of the screen, the Z-factor and standard deviation for biological replicates were calculated. A Z-factor greater 0.5 was considered acceptable and the mean standard deviation across all drugs for each cell line was 0.06. Drug sensitivity was determined by calculating IC50 and area under the curve (AUC) values. Overall, HPV-positive HNSCC cell lines showed greater sensitivity to 13 drugs from different classes. Particularly, HPV-positive HNSCC cells were more sensitive to p38 MAPK and B-Raf inhibitors including LY2228820 (p < 0.01), regorafenib (p < 0.01), sorafenib (p < 0.05) and SB590885 (p < 0.05). On the other hand, HPV-negative HNSCC lines showed increased sensitivity to 30 drugs among these, palbociclib (p < 0.01), a CDK 4/6 inhibitor, and ryuvidine (p Citation Format: Nene N. Kalu, Tuhina Mazumdar, Pan Tong, Li Shen, Jing Wang, Lauren Averett Byers, Faye M. Johnson. Cell-based, high-throughput screen for small molecule inducers of cell death in HPV-associated head and neck cancers. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 3793.
Published: 2016

208. Abstract 393: NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma

Author: Vaishnavi Sambandam, Pan Tong, Jing Wang, Rishi Saigal, Tuhina Mazumdar, Jeffrey N. Myers, Li Shen, Faye M. Johnson, Ming Zhang, Lauren Averett Byers, Mitchell J. Frederick, and Curtis R. Pickering
Subjects: Oncology, Cancer Research, medicine.medical_specialty, Mutation, Cell cycle checkpoint, business.industry, Cancer, medicine.disease_cause, medicine.disease, Head and neck squamous-cell carcinoma, Apoptosis, Internal medicine, medicine, Viability assay, business, PI3K/AKT/mTOR pathway, Exome sequencing
Abstract: Recently published whole exome sequencing studies in head and neck squamous cell carcinoma (HNSCC) tumors revealed that few had therapeutically targetable alterations using current strategies. This finding defines translational gap between genomics and HNSCC treatment. One potential targetable alteration is PIK3CA mutations. However, clinical trials testing PI3K/mTOR pathway inhibitors have had limited success and these inhibitors only lead to cell cycle arrest in PIK3CA mutant HNSCC cell lines. Thus, there is a critical need to identify therapeutic vulnerabilities for common mutation groups, including tumor suppressors, in HNSCC. One of these molecular subgroups is NOTCH1 which is the second most frequently mutated gene in HNSCC, with a 10-15% prevalence of inactivating mutations. Although there are several studies underscoring the importance of NOTCH1 as a tumor suppressor in HNSCC, none has identified a therapy that targets NOTCH1 mutant (mut) HNSCC. Our objective was to identify predictive biomarkers of sensitivity to PI3K/mTOR inhibitors by integrating drug and multiple-omics data. Cell viability with six PI3K/mTOR inhibitors in 68 HNSCC lines was measured by the CellTiter Glo assay. The peak plasma concentration of each drug was used as the cut-off to determine sensitivity. We observed a striking correlation between NOTCH1mut and sensitivity to PI3K/mTOR pathway inhibitors. When fisher's exact test was performed, NOTCH1mut lines were more sensitive to GSK2126458 (P NOTCH1mut lines underwent more apoptosis after GSK2126458 treatment compared to NOTCH1wt lines (PCI15B- 48.1 fold; P Our data suggests that loss of active NOTCH1 signaling confers sensitivity to PI3K/mTOR inhibition. If the combination of NOTCH1 and PI3K/mTOR inhibition leads to apoptosis, this combination could be translated into the clinic. Citation Format: Faye M. Johnson, Vaishnavi Sambandam, Li Shen, Ming Zhang, Rishi Saigal, Pan Tong, Tuhina Mazumdar, Lauren A. Byers, Curtis Pickering, Jeffrey N. Myers, Jing Wang, Mitchell Frederick. NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 393.
Published: 2016

209. Abstract 4665: The combination of polo-like kinase 1 inhibition and erlotinib overcomes T790M-mediated drug resistance in vitro and in vivo in non-small cell lung cancer

Author: Faye M. Johnson, Uma Giri, Monique B. Nilsson, Liguang Wang, Ratnakar Singh, Yuehong Wang, Pan Tong, Jing Wang, Lerong Li, Ruchitha Goonatilake, and John V. Heymach
Subjects: Cancer Research, biology, Chemistry, DNA damage, Cancer, Volasertib, Cell cycle, medicine.disease, respiratory tract diseases, T790M, chemistry.chemical_compound, Oncology, medicine, Cancer research, biology.protein, Epidermal growth factor receptor, Erlotinib, Lung cancer, medicine.drug
Abstract: Introduction: Activation of epidermal growth factor receptor (EGFR) leads to the development and progression of human epithelial cancers, including non-small cell lung cancer (NSCLC). EGFR tyrosine kinase inhibitors (EGFR-TKI) are effective therapy for NSCLC with activating EGFR mutations. However, acquired resistance to EGFR-TKIs is unavoidable and occurs through various molecular mechanisms including the development of T790M secondary EGFR mutations, MET amplification, epithelial-mesenchymal transition (EMT) and other mechanisms. One of potential strategy to overcome EGFR-TKIs is through inhibition of polo-like kinase 1 (PLK1). PLK1 is one of the key regulators of mitotic progression and a DNA damage recovery checkpoint. PLK1 inhibitors are at various stages of clinical development. Our previous studies showed that mesenchymal NSCLC cell lines are more sensitive to PLK1 inhibitor than epithelial ones. This study examines the efficacy of PLK1 inhibition in NSCLC cell lines with acquired resistance to the EGFR-TKI erlotinib. Methods: Erlotinib resistant cell lines were developed in EGFR mutant, erlotinib sensitive cell lines PC9, HCC4006 and HCC827 by chronic exposure to stepwise increased concentrations of erlotinib. The effects of the PLK1 inhibitor volasertib alone or combined with erlotinib on proliferation, apoptosis, cell cycle, EGFR-dependent signaling, DNA damage and DNA damage response signaling were evaluated using CellTiter-Glo assay, TUNEL assay, BrDU incorporation assay, comet assay, western blot and immunofluorescence. Sensitivity of volasertib alone or in combination with erlotinib was also detected in the human tumor xenograft model. The combination index (CI) was calculated by Calcusyn software. Results: Acquired erlotinib resistant NSCLC cell lines with endogenous EGFR mutations (PC9, HCC4006 and HCC827) showed diverse resistance mechanisms: T790M EGFR mutation, MET amplification and EMT. Four of the 6 ER clones that underwent EMT became more sensitive to volasertib. Volasertib and erlotinib demonstrated synergistic effects only in cells bearing T790M EGFR mutations where we observed more pronounced G2M arrest and increased apoptosis. Volasertib alone or in combination showed enhanced DNA damage, activation of CHK1/ATR and CHK2/ATM pathways and an increase in γH2AX foci but only a modest effect on canonical signaling downstream of EGFR. The combination treatment exhibited a pronounced reduction in the size of tumor compared to single agent treatment in subcutaneous xenograft model generated with T790M mutant EGFR TKI-resistant PC9 cell line. Conclusions: These data demonstrate that PLK1 inhibition alone induces apoptosis and DNA damage in EGFR-TKI resistant cell lines with EMT. The combination of volasertib and erlotinib overcomes T790M-mediated drug resistance in vitro and in vivo. Citation Format: Ratnakar Singh, Yuehong Wang, Liguang Wang, Monique Nilsson, Ruchitha Goonatilake, Pan Tong, Lerong Li, Uma Giri, Jing Wang, John V. Heymach, Faye M. Johnson. The combination of polo-like kinase 1 inhibition and erlotinib overcomes T790M-mediated drug resistance in vitro and in vivo in non-small cell lung cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4665.
Published: 2016

210. Abstract 4757: Identification of biomarkers that predict response of head and neck squamous cell carcinoma to mitotic inhibitors

Author: Pan Tong, Tuhina Mazumdar, Jing Wang, Ming Zhang, Li Shen, Shaohua Peng, Faye M. Johnson, Lerong Li, Curtis R. Pickering, Lauren Averett Byers, Mitchell J. Frederick, Jeffrey N. Myers, and Vaishnavi Sambandam
Subjects: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Cancer, Volasertib, Cell cycle, Gene mutation, medicine.disease, PLK1, Head and neck squamous-cell carcinoma, chemistry.chemical_compound, chemistry, In vivo, Apoptosis, Internal medicine, medicine, business
Abstract: Objectives: It is urgent to explore novel biomarkers and therapeutic targets for that are relevant to head and neck squamous cell carcinoma (HNSCC), which is the 6th most common cancer worldwide. Based on a prior drug screen, we identified 3 mitotic inhibitors (AZD7762, AZD1775, volasertib) as effective therapies for HNSCC. Our objective with this study is to identify mechanisms of response and potential biomarkers of response and Methods: Cell viability assays were performed by the CellTiter-Glo Luminescent method in a panel of 68 fingerprinted HNSCC cell lines using the 3 drugs at concentrations of 0.018 to 9.613 μM. Cell cycle, apoptosis and altered pathway protein expression after cells treated by the polo-like kinase 1 (PLK1) inhibitor volasertib were investigated by FACS, TUNEL and western blots respectively. An orthotopic mouse model of HNSCC was used to confirm the antitumor effects of PLK1 inhibition in vivo. To determine the mechanisms of drug sensitivity, we analyzed the correlation between gene expression, protein expression, gene mutation and drug sensitivity using modified two-sample t-tests were performed. The beta-uniform mixture (BUM) model was used to control false discovery rate (FDR). For correlations between drug sensitivity and gene mutations, we performed Fisher's exact test. Results: Using the IC80 values with the peak plasma concentration of each drug as the cut-off to determine sensitivity, 34, 44 and 20 HNSCC cell lines were sensitive AZD1775 (Wee inhibitor), AZD7762 (CHK1/2 inhibitor) and volasertib (PLK1 inhibitor) respectively. HNSCC harboring AJUBA mutations were more sensitive to these 3 inhibitors and those with RAS mutations more resistant. PLK1 inhibition led to G2/M arrest, but only sensitive cell lines underwent substantial apoptosis following PLK1 inhibition. Decreases of the levels of phosphorylated TCTP were observed following treatment with volasertib confirming PLK1 inhibition. There was a significant decrease of tumor volumes and prolongation of survival in the mice bearing orthotopic HNSCC tumors treated with volasertib in vivo. Conclusions: PLK1 inhibition was an effective therapy in vitro and in vivo models of HNSCC. We identified the AJUBA and RAS mutations as potential candidate biomarkers of response to these mitotic inhibitors in HNSCC. This study identified the therapeutic potential of PLK1 as a novel therapeutic target for HNSCC. Citation Format: Ming Zhang, Shaohua Peng, Tuhina Mazumdar, Vaishnavi Sambandam, Li Shen, Pan Tong, Lerong Li, Lauren Byers, Curtis Pickering, Mitchell Frederick, Jeffrey N. Myers, Jing Wang, Faye M. Johnson. Identification of biomarkers that predict response of head and neck squamous cell carcinoma to mitotic inhibitors. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4757.
Published: 2016

211. A Regimen Combining the Wee1 Inhibitor AZD1775 With Histone Deacetylase Inhibitor Vorinostat is Highly Active Against Head and Neck Squamous Cell Carcinoma Harboring High-risk TP53 Mutations

Author: Siquing Fu, Abdullah A. Osman, Mitchell J. Frederick, J.N. Myers, Nene N. Kalu, J. Wang, Ameeta A. Patel, L. Tang, Faye M. Johnson, Natalie L. Silver, and Noriaki Tanaka
Subjects: WEE1 Inhibitor AZD1775, Cancer Research, Radiation, business.industry, medicine.drug_class, Histone deacetylase inhibitor, medicine.disease, Tp53 mutation, Head and neck squamous-cell carcinoma, Regimen, Oncology, medicine, Cancer research, Radiology, Nuclear Medicine and imaging, business, Vorinostat, medicine.drug
Published: 2016

212. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival

Author: Faye M. Johnson, Thomas J. Ow, Merrill S. Kies, Diana Bell, David I. Rosenthal, Heath D. Skinner, Adel K. El-Naggar, Jeffrey N. Myers, Vlad C. Sandulache, Jackson Hamilton, K. Kian Ang, Beth M. Beadle, and Shiva P. Daram
Subjects: Oncology, Adult, Male, medicine.medical_specialty, Neoplasm, Residual, medicine.medical_treatment, Kaplan-Meier Estimate, Cancer Care Facilities, Risk Assessment, Disease-Free Survival, Cohort Studies, Internal medicine, medicine, Carcinoma, Neoplasm, Combined Modality Therapy, Humans, Neoplasm Invasiveness, Survival analysis, Aged, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies, Proportional hazards model, business.industry, Neck dissection, Retrospective cohort study, Chemoradiotherapy, Middle Aged, medicine.disease, Survival Analysis, Texas, Oropharyngeal Neoplasms, Treatment Outcome, Otorhinolaryngology, Response Evaluation Criteria in Solid Tumors, Multivariate Analysis, Carcinoma, Squamous Cell, Neck Dissection, Female, Lymph Nodes, Neoplasm Recurrence, Local, business, Follow-Up Studies
Abstract: Background Oropharyngeal squamous cell carcinoma (OPSCC) is increasing in frequency. We reviewed patients with advanced-stage OPSCC treated with chemoradiation to assess the impact of residual neck disease on survival. Methods We reviewed 202 patients with OPSCC between 1990 and 2010 treated with primary chemoradiation followed by neck dissection. Imaging was analyzed using RECIST (Response Evaluation Criteria In Solid Tumors) 1.1 criteria. Survival was evaluated using both univariate and multivariate analyses. Results Overall survival at 5 years was 89%. Forty-two patients (21%) had residual disease in the neck (pN+). pN+ was associated with greater locoregional recurrence (LRR) and distant metastasis (DM) and decreased survival. No clinicopathologic factors were predictive of pN+. Contrasted posttreatment CT had low sensitivity and specificity. Conclusions In advanced OPSCC pN+, patients have higher rates of LRR and DM. Neither clinicopathologic factors nor posttreatment imaging was predictive of pN+, although increased use of modern imaging may reduce the rate of negative neck dissections. © 2012 Wiley Periodicals, Inc. Head Neck 35: 1454–1460, 2013
Published: 2012

213. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion

Author: Shaohua Peng, Li Zhang, John V. Heymach, John D. Minna, Scott M. Lippman, Faye M. Johnson, Pierre Saintigny, Ignacio I. Wistuba, Luc Girard, and Banibrata Sen
Subjects: Cancer Research, Lung Neoplasms, Mutation, Missense, Gene Expression, Adenocarcinoma of Lung, Antineoplastic Agents, Apoptosis, Kaplan-Meier Estimate, Biology, Adenocarcinoma, Article, Disease-Free Survival, Erlotinib Hydrochloride, EPH receptor A4, Cell Movement, Cell Line, Tumor, Occludin, medicine, Ephrin, Humans, Neoplasm Invasiveness, Lung cancer, Receptor, Extracellular Signal-Regulated MAP Kinases, Cell Proliferation, Proportional Hazards Models, Erythropoietin-producing hepatocellular (Eph) receptor, Receptor, EphA4, Cancer, Epithelial Cells, Cell cycle, medicine.disease, biological factors, Cell biology, Oncology, Case-Control Studies, Multivariate Analysis, Cancer research, Quinazolines, Cisplatin, Ephrins
Abstract: The Eph family of receptors is the largest family of receptor tyrosine kinases, but it remains poorly studied in lung cancer. We aimed to systematically explore the human Eph receptors and their ligands, the ephrins, in lung adenocarcinoma. The prognostic impact of Eph receptor and ephrin gene expression was analyzed using 2 independent cohorts of lung adenocarcinoma. Gene expression profiles in lung adenocarcinoma compared with normal adjacent lung were studied in 3 independent cohorts and in cell lines. Gene expression profiles were validated with quantitative polymerase chain reaction (qPCR) and Western blotting in cell lines. Functional studies to assess the role of Eph receptor A4 (EphA4) were carried out in vitro. The biological effects of EphA4 in lung cancer cell lines were assayed following overexpression and knockdown. Of the 11 Eph receptors and 8 ephrins analyzed, only EphA4 and ephrin A1 gene expression were consistently associated with an improved outcome in patients with lung adenocarcinoma. Expression levels of EphA4 by microarray correlated well with expression levels measured by qPCR and Western blotting. EphA4 overexpression reduced cell migration and invasion but did not affect cell cycle, apoptosis, or drug sensitivity. Surprisingly, EphA4 was expressed at higher levels in cancer compared with non-cancer tissues and cell lines. EphA4 gene expression is associated with an improved outcome in patients with resected lung adenocarcinoma, possibly by affecting cancer cell migration and invasion. Mol Cancer Ther; 11(9); 2021–32. ©2012 AACR.
Published: 2012

214. Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib

Author: Ignacio I. Wistuba, Shaohua Peng, Heidi S. Erickson, Faye M. Johnson, Tuhina Mazumdar, David J. Stewart, Banibrata Sen, Hector Galindo, and Ximing Tang
Subjects: MAPK/ERK pathway, Proto-Oncogene Proteins B-raf, Lung Neoplasms, endocrine system diseases, medicine.drug_class, Dasatinib, Synthetic lethality, Biology, medicine.disease_cause, Tyrosine-kinase inhibitor, Article, hemic and lymphatic diseases, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, medicine, Humans, Lung cancer, skin and connective tissue diseases, neoplasms, Protein Kinase Inhibitors, Cell Proliferation, Mutation, Kinase, General Medicine, medicine.disease, digestive system diseases, Thiazoles, Pyrimidines, Cancer research, medicine.drug
Abstract: During a clinical trial of the tyrosine kinase inhibitor dasatinib for advanced non-small cell lung cancer (NSCLC), one patient responded dramatically and remains cancer-free 4 years later. A comprehensive analysis of his tumor revealed a previously undescribed, kinase-inactivating BRAF mutation ((Y472C)BRAF); no inactivating BRAF mutations were found in the nonresponding tumors taken from other patients. Cells transfected with (Y472C)BRAF exhibited CRAF, MEK (mitogen-activated or extracellular signal-regulated protein kinase kinase), and ERK (extracellular signal-regulated kinase) activation-characteristics identical to signaling changes that occur with previously known kinase-inactivating BRAF mutants. Dasatinib selectively induced senescence in NSCLC cells with inactivating BRAF mutations. Transfection of other NSCLC cells with these BRAF mutations also increased these cells' dasatinib sensitivity, whereas transfection with an activating BRAF mutation led to their increased dasatinib resistance. The sensitivity induced by (Y472C)BRAF was reversed by the introduction of a BRAF mutation that impairs RAF dimerization. Dasatinib inhibited CRAF modestly, but concurrently induced RAF dimerization, resulting in ERK activation in NSCLC cells with kinase-inactivating BRAF mutations. The sensitivity of NSCLC with kinase-impaired BRAF to dasatinib suggested synthetic lethality of BRAF and an unknown dasatinib target. Inhibiting BRAF in NSCLC cells expressing wild-type BRAF likewise enhanced these cells' dasatinib sensitivity. Thus, the patient's BRAF mutation was likely responsible for his tumor's marked response to dasatinib, suggesting that tumors bearing kinase-impaired BRAF mutations may be exquisitely sensitive to dasatinib. Moreover, the potential synthetic lethality of combination therapy including dasatinib and BRAF inhibitors may lead to additional therapeutic options against cancers with wild-type BRAF.
Published: 2012

215. CSK-Homologous Kinase

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

216. Cholecystokinin-2 Receptor

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

217. C-type Lectin-Like Receptor 2

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

218. CD191

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

219. c-K-Ras

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

220. CKIP-1 (CK2 Interacting Protein-1)

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

221. C-type Lectin-Domain Family 1 Member A

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

222. c-FGR

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

223. Chemokine (C-X-C Motif) Ligand 10

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

224. CLEC-2

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

225. cyt-PTPe

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

226. C-Type Mannose Receptor 2

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

227. Cysteine Sulfinic Acid Reductase

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

228. C-type Lectin-Domain Family 1, Member b

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

229. C-type Lectin-Like Receptor 1

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

230. C-type Lectin Domain Family 4 Member E

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

231. CCK(A) Receptor

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

232. c-Src Family of Tyrosine Kinases

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

233. C-type (Calcium-Dependent, Carbohydrate-Recognition Domain) lectin, Superfamily Member 5

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

234. Cek4 (Chicken)

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

235. CRG-5

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

236. Centaurin Delta 3

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

237. Calcium and DAG-Regulated Guanine Nucleotide Exchange Factor II

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

238. c-H-Ras

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

239. Cyclic ADP-Ribose Hydrolase

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

240. CD72 Antigen

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

241. Catenin Beta

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

242. CLEC1B, C-type Lectin-Domain Family 1, Member B

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

243. cADPr Hydrolase

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

244. cAMP Phosphodiesterase-4

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

245. c-N-Ras

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

246. CLK Kinases

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

247. c-SRC

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

248. CCN2: CTGF, FISP12, HCS24, ßIG-M2, HBGF-0.8, Ecogenin, IGFBP8, IGFBP-rP2

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

249. Catenin (Cadherin-Associated Protein), Beta 1 (88kD)

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

250. Cancer Osaka Thyroid Oncogene

Author: Frans van Roy, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, David W. Litchfield, Dave Boucher, Jean-Bernard Denault, Keiko Matsuda, Michisuke Yuzaki, Carlos Repeke, Thiago Garlet, Ana Paula Trombone, Gustavo Garlet, Elcia Maria Silveira, Andreia Vieira, Fernando Cunha, Satoshi Kubota, Masaharu Takigawa, Helena Soares, Sofia Nolasco, João Gonçalves, Armand Bensussan, Anne Marie-Cardine, Sumit Deswal, Wolfgang W. A. Schamel, Leopoldo Santos-Argumedo, Gail A. Bishop, Dima A. Decker, Bruce S. Hostager, Maria Elena Bravo-Adame, Monserrat Alba Sandoval-Hernandez, Oscar Arturo Migueles-Lozano, Yvonne Rosenstein, Pauline Johnson, Asanga Samarakoon, Amy E. Saunders, Kenneth W. Harder, David D. Roberts, David R. Soto-Pantoja, Jeff S. Isenberg, Pedro A. Lazo, Ramiro Barcia, Hsin-Jung Wu, Natarajan Muthusamy, Subbarao Bondada, Shoshana Levy, Sudesh Pawaria, Robert J. Binder, Hisao Masai, Dongli Hu, Jill M. Lahti, Bernhard B. Singer, Richard Horuk, Laurence J. Miller, Jean Morisset, Anita R. Mistry, Christopher A. O’Callaghan, Angharad E. Fenton-May, Michael Reschen, Janet A. Willment, Gordon D. Brown, Leonard Rabinow, Scott A. Ness, Carl E. Creutz, Nan Yagishita-Kyo, Masatoshi Inoue, Mio Nonaka, Hiroyuki Okuno, Haruhiko Bito, Masato Okada, Heung-Chin Cheng, Mohammed Iqbal Hossain, Mohd Aizuddin Kamaruddin, Yuh-Ping Chong, Banibrata Sen, Faye M. Johnson, Paula A. Pino, Astrid E. Cardona, Federico Paroni, Kathrin Maedler, and Randy Y. C. Poon
Published: 2012

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Database

Publisher

500 results on '"Faye M. Johnson"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources